Device Trial Radar · NCT00854295
Prospective Multicenter Post Approval Study of the LPS-Flex Mobile Bearing Knee
Last checked: Nov 19, 2026Latest source record: Feb 14, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
266
Actual
Start
Apr 2009
Primary completion
Jun 2020
Study completion Jun 2021
Sponsor
- Lead sponsor
- Zimmer BiometPublic (ZBH)
- Sponsor type
- Industry
- First posted
- Mar 3, 2009
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of the study is to assess the long-term performance of the NexGen LPS-Flex Mobile Bearing Knee in the treatment of patients with severe knee pain or degenerative knee disease.
Conditions
- Osteoarthritis
- Traumatic Arthritis
- Avascular Necrosis of the Femoral Condyle
- Moderate Varus
- Valgus
- Flexion Deformities
Interventions
NexGen LPS-Flex Mobile Bearing KneeDevice
Total Knee Replacement
Primary outcomes
What the sponsor says the trial is designed to measure.
- Group 2 - Total Knee Society Score (KSS)Time frame: Pre-op, 6 week, 6 month, 1 year, 2 year, 3 year, 4 year, and 5 year
- Group 2 - Number of Subjects With Absence of Radiolucency/Bone LossTime frame: 5 year
- Group 2 - Number of Subjects With Absence of Implant RevisionTime frame: 5 year
5 more outcomes with a free account
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Phoenix Clinical Research
Tamarac, Florida
Advanced Orthopaedics
Auburn Hills, Michigan
Tennessee Orthopaedic Foundation for Education and Research
Knoxville, Tennessee
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.